Adeniyi Oyebade Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Graduate Student

University of Arkansas at Little Rock

grad_student

3 h-index 8 pubs 37 cited

Research Areas

Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Antibiotic Resistance in Bacteria Photonic and Optical Devices Carbon-Based Anode Materials for Metal-Ion Batteries Food composition and properties

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Adeniyi Oyebade's research focuses on the development and application of nanomedicine for therapeutic purposes, with a particular emphasis on cancer treatment and combating bacterial infections. His work has explored the use of doxorubicin-based ionic nanomedicines for combined chemo-phototherapy in cancer, investigating the cellular pathways involved in their efficacy. Oyebade has also studied targeted drug delivery systems, such as the use of epidermal growth factor receptors for delivering rapamycin in pancreatic cancer cells to inhibit proliferation and induce apoptosis. Furthermore, his research extends to combining photothermal therapy with antibiotics for enhanced bacterial killing. Oyebade's publications also touch upon materials science, including carbon-based anode materials for metal-ion batteries and the physicochemical properties of seed oils. He has a significant publication record with key collaborators at the University of Arkansas at Little Rock, including Noureen Siraj and Mujeebat Bashiru.

Metrics

h-index: 3
Publications: 8
Citations: 37

Selected Publications

Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions (2025) DOI
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025) DOI
Comparative Study of the Physicochemical Properties of Oil from Underutilized Seeds of Citrus Paradisi, Citrus Lemon and Citrus Sinensis (2025) DOI
IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024) DOI
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024) DOI
Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods (2024) DOI
Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024) DOI
Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria (2023) DOI